Sponsor Pipeline

Wen-Ming Cao Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 4
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07695259 Olaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast Cancer Elderly Females Recruiting
Disease Areas
Breast Cancer (1)
Get alerts when Wen-Ming Cao's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free